With U.S. stock futures trading mixed this morning on Friday, some of the stocks that may grab investor focus today are as follows:

• Wall Street expects Suncrete Inc. (NASDAQ:RMIX) to post a quarterly loss of 5 cents per share on revenue of $99.98 million before the opening bell, according to data from Benzinga Pro. Suncrete shares fell 1.5% to close at $18.82 on Thursday.
• Applied Materials Inc. (NASDAQ:AMAT) posted better-than-expected financial results for the third quarter and issued strong guidance for the current quarter. Applied Materials guided for fourth-quarter revenue of $10.25 billion, plus or minus $500 million, versus estimates of $9.54 billion. The company anticipates fourth-quarter adjusted earnings of $3.82 to $4.22 per share, versus estimates of $3.69 per share. Applied Materials shares fell 2.5% to close at $534.54 on Thursday.
• Analysts are expecting Bally’s Corp. (NYSE:BALY) to post a quarterly loss of $1.14 per share on revenue of $788.52 million. The company will release earnings after the markets close. Bally’s shares fell 2.2% to $13.20 in after-hours trading.

Check out our premarket coverage here

• Globant SA (NYSE:GLOB) reported mixed second-quarter financial results and cut its FY26 guidance below estimates. Globant reported quarterly earnings of $1.40 per share, which missed the analyst consensus estimate of $1.50 per share. The company reported quarterly sales of $614.417 million, which beat the analyst consensus estimate of $613.062 million. Globant shares dipped 13.6% to $35.43 in the after-hours trading session.
• Sensus Healthcare Inc. (NASDAQ:SRTS) reported worse-than-expected second-quarter financial results. Sensus Healthcare shares dipped 10.1% to $2.84 in the after-hours trading session.

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.